This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.
Millie Mo, PharmD
Advertisement
Articles by Millie Mo, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
2
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
The Next Frontier in Hepatitis B Functional and Virologic Cure
5